[ad_1] Contract research and manufacturing services firm Syngene International Ltd on Monday (March 10) announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines. The state-of-the-art biologics facility, acquired by Syngene USA Inc., a wholly owned subsidiary of Syngene, from Emergent Manufacturing Operations Baltimore, LLC […]
Syngene International Q3 Results | Net profit rises 18% to ₹131 crore, revenue up 11% to ₹944 crore – CNBC TV18
[ad_1] Contract research and manufacturing services firm Syngene International Ltd on Thursday (January 23) reported an 18% year-on-year (YoY) increase in net profit at ₹131 crore for the third quarter that ended December 31, 2024. Company Value Change %Change In the corresponding quarter of the previous fiscal, Syngene International posted a net profit of ₹111 […]
This pharma stock made investors nearly 200% wealthier in a year, Goldman Sachs suggests buying more – CNBC TV18
[ad_1] Goldman Sachs’ top pharma stock picks — Syngene and Neuland — traded lower amid an overall downtrend in the stock market on December 13. However, the brokerage continues to recommend buying them. Company Value Change %Change The shares of Neuland Laboratories traded over 3% lower on NSE at 12:30 pm. However, the stock has […]
Syngene International Block Deal | Stock rises after equity worth ₹706 crore changes hands – CNBC TV18
[ad_1] As many as 82.2 lakh shares or 2% equity of Syngene International worth ₹706 crore changed hands at ₹858.5 apiece in block deals on Tuesday, December 10. Company Value Change %Change On Monday, December 9, CNBC-TV18 reported, citing sources, that biotechnology firm Biocon Ltd was likely to sell 2% stake in Syngene International via […]
US House passes Biosecure Act – How will it impact Indian Pharma – CNBC TV18
[ad_1] The US House of Representatives on Monday passed the BIOSECURE Act by 306 votes to 81, which will prevent drug companies from doing business with certain Chinese biotechs within eight years. The act has specifically named five chinese companies, BGI Genomics, MGI Tech, Complete Genomics, WuXi AppTec and Wuxi Biologics to whom the act […]